UY32127A - Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación - Google Patents
Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparaciónInfo
- Publication number
- UY32127A UY32127A UY0001032127A UY32127A UY32127A UY 32127 A UY32127 A UY 32127A UY 0001032127 A UY0001032127 A UY 0001032127A UY 32127 A UY32127 A UY 32127A UY 32127 A UY32127 A UY 32127A
- Authority
- UY
- Uruguay
- Prior art keywords
- powder
- reduced
- processes
- containing nicotine
- preparation procedures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Abstract
Un granulado que contiene nicotina, reducido en polvo, que comprende una mezcla homogénea de nicotina o un derivado de nicotina farmacéuticamente aceptable y un excipiente. El granulado tiene un tamaño de partícula de al menos 150 um. Método para la preparación de un granulado que contiene nicotina para la preparación de productos farmacéuticos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08016336A EP2177213B1 (en) | 2008-09-17 | 2008-09-17 | Nicotine-containing granulate |
Publications (1)
Publication Number | Publication Date |
---|---|
UY32127A true UY32127A (es) | 2010-04-30 |
Family
ID=40091848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001032127A UY32127A (es) | 2008-09-17 | 2009-09-17 | Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación |
Country Status (17)
Country | Link |
---|---|
US (1) | US10413512B2 (es) |
EP (1) | EP2177213B1 (es) |
AR (1) | AR073604A1 (es) |
AU (1) | AU2009294964B2 (es) |
CA (1) | CA2734402C (es) |
DK (1) | DK2177213T3 (es) |
ES (1) | ES2401912T3 (es) |
HR (1) | HRP20130161T1 (es) |
MX (1) | MX2011002696A (es) |
NZ (1) | NZ591198A (es) |
PA (1) | PA8842701A1 (es) |
PL (1) | PL2177213T3 (es) |
PT (1) | PT2177213E (es) |
SI (1) | SI2177213T1 (es) |
UY (1) | UY32127A (es) |
WO (1) | WO2010031536A1 (es) |
ZA (1) | ZA201101123B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2198865T3 (pl) * | 2008-12-19 | 2012-04-30 | Siegfried Ltd | Produkt zawierający nikotynę |
CA2904416A1 (en) | 2013-03-07 | 2014-09-12 | Amneal Pharmaceuticals, LLC | Stabilization of moisture-sensitive drugs |
US11779045B2 (en) | 2013-10-03 | 2023-10-10 | Altria Client Services Llc | Dissolvable-chewable exhausted-tobacco tablet |
DK3052081T3 (da) * | 2013-10-03 | 2021-01-18 | Altria Client Services Llc | Pastil |
US9351936B2 (en) | 2013-10-03 | 2016-05-31 | Altria Client Services Llc | Nicotine lozenge |
US10105320B2 (en) * | 2013-10-03 | 2018-10-23 | Altria Client Services | Soluble fiber lozenge |
US9999243B2 (en) | 2013-10-03 | 2018-06-19 | Altria Client Services Llc | Exhausted tobacco lozenge |
US10244786B2 (en) | 2013-10-03 | 2019-04-02 | Altria Client Services Llc | Tobacco lozenge |
CN108024966A (zh) * | 2015-09-14 | 2018-05-11 | 默克专利股份有限公司 | 具有受控延迟活性成分释放的制剂 |
US11311623B2 (en) | 2016-04-21 | 2022-04-26 | Fertin Pharma A/S | Nicotine delivery product, related uses and oral dosage forms, and methods of production |
US11406630B2 (en) | 2017-06-23 | 2022-08-09 | Ncp Nextgen A/S | Nicotine pouch |
JP7398374B2 (ja) * | 2017-12-08 | 2023-12-14 | フェルティン ファルマ アー/エス | 固形経口ニコチン製剤 |
WO2019110072A1 (en) | 2017-12-08 | 2019-06-13 | Fertin Pharma A/S | Nicotine tablet |
EP3993646B1 (en) * | 2019-07-05 | 2023-08-16 | Swedish Match North Europe AB | An oral pouched nicotine product including a filling material comprising nicotine-containing particles |
WO2021099571A1 (en) | 2019-11-20 | 2021-05-27 | Swedish Match North Europe Ab | An oral pouched nicotine product including a filling material comprising nicotine particles |
US11672862B2 (en) * | 2019-12-09 | 2023-06-13 | Nicoventures Trading Limited | Oral products with reduced irritation |
US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
US20220313678A1 (en) * | 2021-04-06 | 2022-10-06 | Altria Client Services Llc | Spray dried nicotine for inclusion in oral products |
US20220313614A1 (en) * | 2021-04-06 | 2022-10-06 | Altria Client Services Llc | Encapsulated nicotine granules and methods of preparation thereof |
US20220354785A1 (en) * | 2021-04-22 | 2022-11-10 | Nicoventures Trading Limited | Oral lozenge products |
CN114304712A (zh) * | 2021-12-17 | 2022-04-12 | 深圳市元雾科技有限公司 | 一种液体高负载的尼古丁口含制品颗粒及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI104787B (fi) | 1989-06-07 | 2000-04-14 | Xyrofin Oy | Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi |
SE8904295D0 (sv) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Smoking substitute |
US5135753A (en) * | 1991-03-12 | 1992-08-04 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
US6276917B1 (en) * | 1999-01-28 | 2001-08-21 | Botanicals International | Powder processing apparatus |
FR2792200B3 (fr) * | 1999-04-16 | 2001-06-08 | Unicliffe Ltd | Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer |
DE19943496C1 (de) | 1999-09-10 | 2001-05-17 | Suedzucker Ag | Direkt verpressbarer Rohstoff für Komprimate |
WO2002076605A1 (de) | 2001-03-23 | 2002-10-03 | Symrise Gmbh & Co. Kg | Verfahren zur herstellung von einkapselungen |
DK1803444T3 (en) | 2002-12-20 | 2019-02-25 | Niconovum Ab | PROCEDURE FOR PREPARING A NICOTIC PARTICULATE MATERIAL WITH A CRYSTALLINE CELLULOSE (ESPECIALLY MCC) |
US20070269492A1 (en) * | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
WO2008012071A2 (en) | 2006-07-24 | 2008-01-31 | Antares Pharma Ipl Ag | Pharmaceutical compositions of nicotine and methods of use thereof |
-
2008
- 2008-09-17 EP EP08016336A patent/EP2177213B1/en active Active
- 2008-09-17 PL PL08016336T patent/PL2177213T3/pl unknown
- 2008-09-17 DK DK08016336.3T patent/DK2177213T3/da active
- 2008-09-17 SI SI200830890T patent/SI2177213T1/sl unknown
- 2008-09-17 ES ES08016336T patent/ES2401912T3/es active Active
- 2008-09-17 PT PT80163363T patent/PT2177213E/pt unknown
-
2009
- 2009-09-16 WO PCT/EP2009/006676 patent/WO2010031536A1/en active Application Filing
- 2009-09-16 NZ NZ591198A patent/NZ591198A/en unknown
- 2009-09-16 US US13/058,769 patent/US10413512B2/en active Active
- 2009-09-16 CA CA2734402A patent/CA2734402C/en active Active
- 2009-09-16 MX MX2011002696A patent/MX2011002696A/es active IP Right Grant
- 2009-09-16 AU AU2009294964A patent/AU2009294964B2/en active Active
- 2009-09-17 AR ARP090103574A patent/AR073604A1/es unknown
- 2009-09-17 UY UY0001032127A patent/UY32127A/es not_active Application Discontinuation
- 2009-09-17 PA PA20098842701A patent/PA8842701A1/es unknown
-
2011
- 2011-02-11 ZA ZA2011/01123A patent/ZA201101123B/en unknown
-
2013
- 2013-02-25 HR HRP20130161AT patent/HRP20130161T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
MX2011002696A (es) | 2011-04-05 |
PT2177213E (pt) | 2013-02-21 |
US20110165253A1 (en) | 2011-07-07 |
EP2177213A1 (en) | 2010-04-21 |
EP2177213B1 (en) | 2013-01-02 |
AU2009294964B2 (en) | 2012-12-13 |
AU2009294964A1 (en) | 2010-03-25 |
NZ591198A (en) | 2012-03-30 |
DK2177213T3 (da) | 2013-02-11 |
HRP20130161T1 (hr) | 2013-03-31 |
WO2010031536A1 (en) | 2010-03-25 |
AR073604A1 (es) | 2010-11-17 |
CA2734402C (en) | 2013-05-14 |
SI2177213T1 (sl) | 2013-03-29 |
PL2177213T3 (pl) | 2013-08-30 |
US10413512B2 (en) | 2019-09-17 |
PA8842701A1 (es) | 2010-04-21 |
CA2734402A1 (en) | 2010-03-25 |
ZA201101123B (en) | 2012-04-25 |
ES2401912T3 (es) | 2013-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY32127A (es) | Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación | |
UY30537A1 (es) | Formulaciones de flibanserina y metodo para fabricarlas | |
NI201600093A (es) | Formulación compuesta para administración oral que comprende ezetimibe y rosuvastatina | |
CY1117434T1 (el) | Φαρμακευτικες μορφες απιξαμπανης | |
UY39192A (es) | Dispersión sólida, proceso para prepararla y forma de dosificación farmacéutica suministrable por vía oral que la comprende | |
AR089578A1 (es) | Composiciones, metodos para tratar el virus de la hepatitis c y proceso de preparacion | |
UY31867A (es) | Nuevas formulaciones farmacéuticas sólidas que comprenden bibw 2992 | |
TWI265812B (en) | Pharmaceutical safety dosage forms | |
SG158870A1 (en) | Bendamustine pharmaceutical compositions for lyophilisation | |
CY1111897T1 (el) | Απαραβιαστες φαρμακευτικες μορφες δοσολογιας δια του στοματος περιλαμβανουσες ενα οπιουχο αναλγητικο | |
AR062509A1 (es) | Proceso para preparar comprimidos de dihidrocloruro de pramipexol | |
MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
EA200801580A1 (ru) | Новые производные пирониндола и способ их получения | |
TNSN07337A1 (en) | Pharmaceutical composition comprising an indolylmaleimide derivative | |
AR095159A2 (es) | Una composición farmacéutica en forma de cápsula para administración oral | |
MX2013007661A (es) | Derivados de fenil-isoxazol y procedimiento para la preparacion de los mismos. | |
NO20054417L (no) | Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter | |
AR066000A1 (es) | Procedimiento para preparar comprimidos de dihidrocloruro de pramipexol | |
ATE458748T1 (de) | Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel | |
MX2017015322A (es) | Composicion farmaceutica oral de isotretinoin. | |
UA105285C2 (uk) | Тверда фармацевтична композиція раміприлу і безилату амлодипіну і її отримання | |
AU2014226192A8 (en) | Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles | |
PE20160245A1 (es) | Composicion farmaceutica anti-tuberculosis estable en una forma de un comprimido dispersable que comprende granulos de isoniazid y granulos de rifapentina y su proceso de preparacion | |
ECSP16005208A (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20181114 |